TiGenix logo — Pioneering regenerative solutions for joint health and mobil...

TiGenix

Pioneering regenerative solutions for joint health and mobility.

Founded 2000 Private Equity Total: $69.00M Biotechnology, Health Care

General Information

Company Name TiGenix
Founded Year 2000
Industries Biotechnology, Health Care
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with TiGenix. To contact TiGenix, visit tigenix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About TiGenix

TiGenix is a Belgian biomedical company specializing in innovative local treatments for damaged and osteoarthritic joints. Utilizing regenerative medicine, the company's solutions are developed through controlled clinical studies for long-lasting effects. Founded in 2000 as a spin-off from the Catholic University of Leuven and the University of Ghent, TiGenix is focused on building a product portfolio addressing musculoskeletal issues, particularly cartilage damage, which severely impacts patients' mobility and functionality. In 2009, TiGenix expanded its portfolio by acquiring Orthomimetics Ltd. With its last investment being an €8.70M Private Equity Round on 25 November 2015, TiGenix aims to pioneer regenerative solutions for joint health and mobility, operating within the Biotechnology and Health Care industries.

Taxonomy: Regenerative Medicine, Biomedical Research, Joint Health, Osteoarthritis, Local Treatments, Clinical Studies, Musculoskeletal Issues, Cartilage Damage, Mobility Solutions, University Spin-off, Orthomimetics Ltd, Belgium-based Company, Innovative Treatments, Biomedical Innovation, Regenerative Solutions

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round €8.70M -
25 Nov 2015
Debt Financing $13.70M 1
Kreos Capital
25 Dec 2013
Private Equity Round €12.00M -
20 Nov 2013
Private Equity Round €6.50M -
18 Jul 2013
Private Equity Round $8.60M 1
Crede CapitalGroup
01 Dec 2012
Private Equity Round $7.50M 2
Limburg Startup, NV Industriebank LIOF
25 Jun 2009
Venture Round €12.00M 3
Capricorn Venture Partners, Auriga Partners +1
02 Oct 2003

TiGenix Alternatives & Competitors

View All Alternatives
TiGenix vs
Amplicore Inc.
Amplicore Inc. United States

At Amplicore, we develop injectable therapeutics to serve unmet medical needs in musculoskeletal dis...

Seed
7 employees
Biotechnology, Health Care
TiGenix vs
ATRO Medical BV
ATRO Medical BV The Netherlands

Move away from knee pain with our Meniscus Prosthesis.

Grant
12 employees
Biotechnology, Health Care
TiGenix vs
GyroTools LLC
GyroTools LLC Switzerland

Solutions and Services for Research in Magnetic Resonance Imaging and Spectroscopy

4 employees
Biotechnology, Education

FAQ About TiGenix

Pioneering regenerative solutions for joint health and mobility.
TiGenix was founded in 2000.
TiGenix operates in Biotechnology and Health Care. Its work centres on Regenerative Medicine, Biomedical Research, Joint Health and Osteoarthritis.
TiGenix has completed 7 funding rounds, raising a total of $69.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to TiGenix include Amplicore Inc., ATRO Medical BV, GyroTools LLC, Cartilage Inc., Histogenics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TiGenix and Amplicore Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TiGenix, https://bouncewatch.com/company/tigenix, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes